Boston Common Asset Management, LLC Novo Nordisk A S Transaction History

Boston Common Asset Management, LLC

  • $3.84 Billion
  • Q3 2024

A detailed history of Boston Common Asset Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Boston Common Asset Management, LLC holds 50,293 shares of NVO stock, worth $4.41 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
50,293
Previous 46,174 8.92%
Holding current value
$4.41 Million
Previous $6.59 Million 9.15%
% of portfolio
0.16%
Previous 0.17%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024
BUY
$119.07 - $145.42 $490,449 - $598,984
4,119 Added 8.92%
50,293 $5.99 Million
Q2 2024

Jul 08, 2024
SELL
$122.71 - $146.91 $470,224 - $562,959
-3,832 Reduced 7.66%
46,174 $6.59 Million
Q1 2024

Apr 11, 2024
SELL
$102.11 - $135.92 $14,499 - $19,300
-142 Reduced 0.28%
50,006 $6.42 Million
Q4 2023

Jan 09, 2024
SELL
$87.78 - $105.45 $384,739 - $462,187
-4,383 Reduced 8.04%
50,148 $5.19 Million
Q3 2023

Oct 11, 2023
SELL
$90.94 - $199.54 $161,054 - $353,385
-1,771 Reduced 3.15%
54,531 $4.96 Million
Q2 2023

Jul 24, 2023
SELL
$155.98 - $172.65 $2.53 Million - $2.81 Million
-16,247 Reduced 22.39%
56,302 $9.11 Million
Q1 2023

May 17, 2023
BUY
$132.34 - $159.14 $312,851 - $376,206
2,364 Added 3.37%
72,549 $11.5 Million
Q4 2022

Jan 26, 2023
SELL
$102.55 - $135.33 $358,925 - $473,655
-3,500 Reduced 4.75%
70,185 $9.5 Million
Q3 2022

Oct 20, 2022
SELL
$95.28 - $116.93 $79,844 - $97,987
-838 Reduced 1.12%
73,685 $7.34 Million
Q2 2022

Aug 10, 2022
SELL
$103.24 - $121.81 $1.02 Million - $1.2 Million
-9,842 Reduced 11.67%
74,523 $8.3 Million
Q1 2022

May 16, 2022
SELL
$93.1 - $112.54 $2.42 Million - $2.92 Million
-25,986 Reduced 23.55%
84,365 $9.37 Million
Q4 2021

Jan 31, 2022
SELL
$95.88 - $117.08 $325,896 - $397,954
-3,399 Reduced 2.99%
110,351 $12.4 Million
Q3 2021

Nov 12, 2021
BUY
$84.42 - $106.62 $313,113 - $395,453
3,709 Added 3.37%
113,750 $10.9 Million
Q2 2021

Aug 19, 2021
BUY
$67.66 - $84.76 $421,860 - $528,478
6,235 Added 6.01%
110,041 $9.22 Million
Q1 2021

May 14, 2021
SELL
$67.06 - $75.82 $76,515 - $86,510
-1,141 Reduced 1.09%
103,806 $7 Million
Q4 2020

Feb 05, 2021
SELL
$63.89 - $73.8 $1.7 Million - $1.96 Million
-26,549 Reduced 20.19%
104,947 $7.33 Million
Q3 2020

Nov 10, 2020
BUY
$63.69 - $70.22 $293,674 - $323,784
4,611 Added 3.63%
131,496 $9.13 Million
Q2 2020

Aug 10, 2020
SELL
$58.54 - $67.94 $441,215 - $512,063
-7,537 Reduced 5.61%
126,885 $8.31 Million
Q1 2020

May 08, 2020
BUY
$49.46 - $64.78 $296 - $388
6 Added 0.0%
134,422 $8.09 Million
Q4 2019

Jan 28, 2020
SELL
$49.86 - $58.26 $245,111 - $286,406
-4,916 Reduced 3.53%
134,416 $7.78 Million
Q3 2019

Nov 07, 2019
SELL
$47.54 - $53.43 $66,936 - $75,229
-1,408 Reduced 1.0%
139,332 $7.2 Million
Q2 2019

Jul 26, 2019
SELL
$46.79 - $52.47 $1.52 Million - $1.7 Million
-32,430 Reduced 18.73%
140,740 $7.18 Million
Q1 2019

May 03, 2019
BUY
$46.36 - $52.63 $780,702 - $886,289
16,840 Added 10.77%
173,170 $9.06 Million
Q4 2018

Jan 25, 2019
BUY
$41.54 - $47.25 $68,457 - $77,868
1,648 Added 1.07%
156,330 $7.2 Million
Q3 2018

Nov 01, 2018
BUY
$46.76 - $51.24 $228,609 - $250,512
4,889 Added 3.26%
154,682 $7.29 Million
Q2 2018

Aug 06, 2018
BUY
$44.29 - $50.42 $61,607 - $70,134
1,391 Added 0.94%
149,793 $6.91 Million
Q1 2018

Apr 26, 2018
BUY
$48.49 - $58.14 $132,911 - $159,361
2,741 Added 1.88%
148,402 $7.31 Million
Q4 2017

Feb 07, 2018
BUY
$47.53 - $53.73 $114,642 - $129,596
2,412 Added 1.68%
145,661 $7.82 Million
Q3 2017

Nov 13, 2017
BUY
$41.15 - $49.22 $82,464 - $98,636
2,004 Added 1.42%
143,249 $6.9 Million
Q2 2017

Aug 14, 2017
BUY
N/A
141,245
141,245 $6.06 Million

Others Institutions Holding NVO

# of Institutions
1,956
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $198B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Boston Common Asset Management, LLC Portfolio

Follow Boston Common Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Common Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Common Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email